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Age as a risk factor for acute mountain sickness 
upon rapid ascent to 3,700 m among young  
adult Chinese men
Background: The aim of this study was to explore the relationship between age and acute 
mountain sickness (AMS) when subjects are exposed suddenly to high altitude.
Methods: A total of 856 young adult men were recruited. Before and after acute altitude 
exposure, the Athens Insomnia Scale score (AISS) was used to evaluate the subjective sleep 
quality of subjects. AMS was assessed using the Lake Louise scoring system. Heart rate (HR) 
and arterial oxygen saturation (SaO
2
) were measured.
Results: Results showed that, at 500 m, AISS and insomnia prevalence were higher in older 
individuals. After acute exposure to altitude, the HR, AISS, and insomnia prevalence increased 
sharply, and the increase in older individuals was more marked. The opposite trend was observed 
for SaO
2
. At 3,700 m, the prevalence of AMS increased with age, as did severe AMS, and AMS 
symptoms (except gastrointestinal symptoms). Multivariate logistic regression analysis showed 
that age was a risk factor for AMS (adjusted odds ratio [OR] 1.07, 95% confidence interval [CI] 
1.01–1.13, P0.05), as well as AISS (adjusted OR 1.39, 95% CI 1.28–1.51, P0.001).
Conclusion: The present study is the first to demonstrate that older age is an independent 
risk factor for AMS upon rapid ascent to high altitude among young adult Chinese men, and 
pre-existing poor subjective sleep quality may be a contributor to increased AMS prevalence 
in older subjects.
Keywords: acute mountain sickness, age, Athens Insomnia Scale, rapid ascent, sleep
Introduction
In recent years, the number of people ascending to high altitudes worldwide has clearly 
increased. However, acute mountain sickness (AMS) is a major obstacle faced by 
many people after arrival at high altitudes. AMS is a common syndrome encountered 
particularly by lowlanders after rapidly ascending to altitudes above 2,500 m.1 This 
syndrome is characterized by headache, dizziness or lightheadedness, gastrointestinal 
symptoms (anorexia, nausea, or vomiting), weakness or fatigue, and insomnia.2 Among 
these symptoms, headache is the most frequent and essential for final AMS diagnosis. 
Although self-limiting, AMS may develop into fatal high altitude pulmonary or cerebral 
edema in a small number of people.3 Therefore, prevention of AMS is particularly 
important. Research on risk factors for AMS (eg, female sex and younger age)4 is 
beneficial for the prevention of AMS, although further investigations are needed to 
establish these risk factors.5
With the development of transportation, rapid ascension to high altitudes is becoming 
common and easy. However, as yet, there has been no large-scale epidemiological 
investigation into the relationship between age and AMS upon rapid ascent to high 
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altitudes. Thus, the relationship between age and AMS upon 
acute exposure to high altitudes remains unclear. Given that 
past literature6–8 indicated a tendency for older adults to be 
at greater risk of AMS than younger adults, we hypothesized 
that older age would increase the prevalence of AMS upon 
rapid ascent to high altitude. Therefore, this study uses a cross-
sectional design aiming to explore the relationship between 
age and AMS in subjects suddenly exposed to high altitude.
Methods
subjects and design
In the present study, 987 adult Chinese men aged 18 years 
were recruited in June 2012. All subjects were lowlanders, 
without preceding altitude exposure during the previous half 
year, and none suffered from cardiopulmonary disease or 
was currently taking any medicines (eg, vitamins, cold cure, 
etc). Prior to the investigation, all subjects provided written 
informed consent approved by the Ethics Review Board of 
Xinqiao Hospital, Second Affiliated Hospital of Third Mili-
tary Medical University (decision number: 2012015). The 
study protocol was registered in the Chinese Clinical Trial 
Registry (http://www.chictr.org; registration no. ChiCTR-
RCS-12002232). The investigation conforms with the prin-
ciples outlined in the Declaration of Helsinki.
One week before ascending to 3,700 m, all subjects were 
interviewed and underwent a routine physical examination 
(echocardiogram, electrocardiogram, transcranial Doppler, 
chest X-ray, heart rate [HR], blood pressure [BP], and arterial 
oxygen saturation [SaO
2
]). Height and weight were measured 
with standard methods, and body mass index (BMI) was 
obtained by the formula (weight [kg] divided by height squared 
[m2]). In addition, sleep status of the subjects was investigated 
using the Athens Insomnia Scale score (AISS).9 Subjects’ 
demographic characteristics (age, race [Chinese Han, Miao, 
Man, Tibetan, etc], education, drinking10 and smoking11 habits, 
etc) were recorded in the questionnaire. In the morning, all sub-
jects ascended by plane from 500 m to 3,700 m within 2 hours, 
in batches (with a 1-day interval between batches). After arrival 
at 3,700 m, all subjects undertook the same daily regimen and 
refrained from vigorous exercise. On the morning of the second 
day at 3,700 m, all subjects completed the Athens Insomnia 
Scale (AIS)9 and Lake Louise Score (LLS)2 questionnaires. HR 
and SaO
2 
were measured. All identifying characteristics (name, 
age, etc) were concealed before data analysis.
Acute mountain sickness assessment
In the present study, the LLS system2 was used for the 
diagnosis of AMS in subjects. The LLS questionnaire 
comprised five items: headache, dizziness or lightheadedness, 
gastrointestinal symptoms (anorexia, nausea, vomiting), 
fatigue and/or weakness, and insomnia. Each item was 
rated on a four-point Likert scale (0= not at all, 1= mild, 
2= moderate, and 3= severe), with total scores varying from 
0 to 15. Subjects completed their questionnaire after waking 
in the morning. AMS was determined when a subject reported 
a headache and one or more of the other symptoms as well 
as an LLS of 3. The AMS was then classified as mild (LLS 
3 or 4) or serious (LLS 5).
Physiological parameter measurements
After completion of the LLS questionnaire, the HR, SaO
2
, and 
BP values of the subjects were measured after a 15-minute 
rest in a comfortable chair. HR and SaO
2
 values were obtained 
with finger-pulse oximetry (Onyx 9500; Nonin Medical, Inc., 
Plymouth, MN, USA). BP was measured with a sphygmo-
manometer (OMRON HEM-6200; Omron Health Care, Inc., 
Bannockburn, IL, USA). Three consecutive measurements 
for all parameters were obtained, and the mean value of the 
three measurements was used in the analysis.
sleep assessment
Sleep status of the subjects in the past month was assessed 
using the AIS.9 The AIS includes eight items: the first five 
items assess sleep procedure (sleep induction, night awakening, 
awakening in the early morning, total sleep duration, and total 
quality of sleep), and the last three items estimate decreased 
sense and functioning, and sleepiness in the next day. Each 
item is rated from 0 to 3 using a four-point Likert scale (0= no 
event, 1= mild, 2= moderate, and 3= severe). Subjects with an 
AIS score 6 were considered to be suffering from insomnia.12 
The AIS is considered an excellent instrument for assessing 
subjective sleep quality in both clinical and study settings as it 
has good reliability and validity9 and is easy to complete.13
statistical analyses
Data are shown as mean ± standard deviation, median (inter-
quartile range), or n (%), and were analyzed using SPSS ver-
sion 13.0 (IBM Corporation, Armonk, NY, USA). All tests 
were two-tailed, and a P-value 0.05 was considered signifi-
cant. The distribution normality of the parameters was tested 
using the Kolmogorov–Smirnov test. Mean values were 
compared using the Student’s t-test. The Chi-squared test 
was used to assess frequencies. The Mann–Whitney U-test 
was used for the comparison of non-normally distributed 
data. Relationship between LLS and age, BMI, and other 
variables, as well as between age and BMI, BP, and other 
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variables, was determined using the Spearman correlation 
test. Before the multivariate analysis, an odds ratio (OR) 
with 95% confidence intervals (CIs) for AMS associated 
with risk factors was determined using logistic regression. 
On univariate analysis, factors with a P-value 0.10 were 
entered into multivariate logistic regression analysis. The 
backward stepwise likelihood ratio test was used to determine 
the independent factors associated with AMS.
In the present study, the dependent variable was AMS 
and recorded as 0= no and 1= yes. The independent variables 
were age, BMI, race, education, smoking status, drinking 
status, physiological parameters, and AISS. We recorded the 
age value as 0 (20 years), 1 (25 years), 2 (30 years), 
and 3 (35 years).
Results
subjects
We enrolled 987 participants at 500 m, 79 of whom were 
excluded for incomplete data or preceding exposure to high 
altitude. In addition, 22 Tibetan subjects were removed from 
the study because of the small sample size. After arrival at 
3,700 m, one subject withdrew from the study because of high 
altitude pulmonary edema, and a further 29 subjects withdrew 
due to severe headache, diarrhea, or other unknown reasons. 
Thus, we analyzed data obtained from the remaining 856 sub-
jects. Of these, 195 subjects were aged 18–20 years, 314 were 
aged 21–25 years, 238 were aged 26–30 years, and 109 were 
aged 31–35 years. The mean age in the groups aged 20, 
21–25, 26–30, and 31–35 years was 19, 22, 27, and 33 years, 
respectively. Increase in BMI was consistent with increase 
in age (21.1±2.4, 22.0±2.3, 22.3±2.5, and 23.6±2.8 kg/m2 in 
the four age groups, respectively). Except for age (P0.001) 
and BMI (P0.001), no statistically significant differences 
in smoking and drinking status, race, and education were 
observed between the four age groups.
Acute mountain sickness
At an altitude of 3,700 m, the LLS in the age groups 20, 
21–25, 26–30, and 31–35 years was 3.4±2.1, 3.3±2.1, 3.9±2.3, 
and 4.6±2.1, respectively. Differences in LLS between the 
four groups (P0.05 or P0.01) were significant, except for 
between the age groups 20 years and 21–25 years (P=0.68).
Accordingly, the increased prevalence of AMS was con-
sistent with the increase in LLS (54.36%, 59.55%, 68.07%, 
and 73.39% in the four groups, respectively). The prevalence 
of AMS in the 20 and 21–25 years age groups was signifi-
cantly lower than in the 26–30 and 31–35 years age groups 
(P0.05 or P0.01). Notably, the prevalence of severe AMS 
increased with increasing age (Table 1). In addition, the over-
all prevalence of AMS at the 3,700 m altitude was 62.38%.
In terms of AMS symptoms, the most common were 
headache (74.88%), followed by weakness or fatigue 
(73.36%), dizziness or lightheadedness (73.23%), difficulty 
sleeping (66.59%), and the prevalence of gastrointestinal 
symptoms is relatively lower than the prevalence of other 
AMS symptoms (22.43%). Moreover, the prevalence of AMS 
symptoms clearly increased with age (Figure 1), and the dif-
ference in the prevalence of headache, insomnia, and weak-
ness or fatigue reached statistical significance (P0.001, 
P0.001, and P0.01, respectively). 
Physiological parameters
At 500 m, the HR and SaO
2
 for the whole group were 
68±9 beats/minute and 98.1%±0.9%, respectively. No signifi-
cant differences between the four age groups were observed 
in both HR and SaO
2 
(both P0.05) (Figure 2).
After arrival at 3,700 m, the mean HR for the whole group 
increased to 84±12 beats/minute. Conversely, the mean SaO
2 
decreased to 88.8%±2.9%. This tendency was observed in all 
four age groups. Furthermore, significant differences between 
these groups were observed in HR (Figure 3), and there was 
a tendency for SaO
2
 to decrease with increasing age.
Athens Insomnia scale score
The AISS and prevalence of insomnia in each group are 
shown in Table 2. AISS increased with increasing age at 
both 500 m and 3,700 m, and the AISS obtained at 3,700 m 
was significantly higher than that obtained at 500 m (each 
P0.001). The same tendency was observed in insomnia 
prevalence. Upon rapid ascent from 500 m to 3,700 m, the 
Table 1 Comparison of the prevalence of acute mountain sickness
Variables Age 20 
years (n=195)
Age 21–25 
years (n=314)
Age 26–30 
years (n=238)
Age 31–35 
years (n=109)
no AMs 89 (45.64) 127 (40.45) 76 (31.93) 29 (26.61)
Mild AMs 56 (28.72) 93 (29.61) 58 (24.37) 27 (24.77)
severe AMs 50 (25.64) 94 (29.94) 104 (43.70)#* 53 (48.62)#**
Notes: Values are presented as n (%). Compared with the group aged 20 years: #P0.001. Compared with the group aged 21–25 years: *P0.01, **P0.001.
Abbreviation: AMs, acute mountain sickness.
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increase in insomnia prevalence in the group aged 31–35 years 
(2.79 times) was a little more than in the other three groups 
(2.74, 2.58, and 2.69 times in groups aged 20, 21–25, and 
26–30 years, respectively). Consequently, the prevalence 
of insomnia was significantly higher in the group aged 
31–35 years than in the other three groups (each P0.001, 
Table 2). Insomnia prevalence in the whole group at 500 m 
and 3,700 m was 18.57% and 49.88%, respectively.
Correlational analysis
On simple univariate analysis, age, HR, and AISS were 
positively correlated with LLS, whereas SaO
2
 was negatively 
correlated with LLS (Table 3). No significant correlations 
were found between LLS and other variables (BMI, race, etc). 
Additionally, age was significantly positively correlated with 
BMI, HR, and AISS, but significantly negatively correlated 
with SaO
2 
(data not shown).
Figure 1 Comparisons of the prevalence of acute mountain sickness symptoms.
Notes: Comparisons were performed with chi-squared tests: *P0.05, **P0.01, ***P0.001.
Abbreviations: AMS, acute mountain sickness; DL, dizziness or lightheadedness; DS, difficulty sleeping; GS, gastrointestinal symptoms; WF, weakness or fatigue.
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Figure 2 heart rate (A) and arterial oxygen saturation (B) of the four age groups at 500 m.
Abbreviations: hr, heart rate; saO2, arterial oxygen saturation.
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logistic regression analysis
On univariate logistic regression analysis, AMS was associ-
ated with age (OR 1.035, 95% CI 1.003–1.068, P0.05), 
smoking (OR 0.633, 95% CI 0.462–0.868, P0.01), SaO
2
 
(OR 0.933, 95% CI 0.890–0.978, P0.01), and AISS (OR 
1.411, 95% CI 1.333–1.495, P0.001), but not with BMI 
and other variables (race, education, drinking, etc).
A multivariate analysis that considered previous age, 
smoking, SaO
2
, and AISS showed that all variables except 
smoking and SaO
2
 were significantly associated with AMS 
(Table 4).
Discussion
To our knowledge, this is the first large-scale epidemiological 
investigation of the relationship between age and AMS upon 
rapid ascent to high altitude. The main finding of the present 
study is the significantly higher prevalence of AMS in the 
older, young adults than in the younger, young adults after 
rapid ascent from 500 m to 3,700 m. Furthermore, older age, 
one of the risk factors for AMS, was identified by univariate 
and multivariable analyses in the present study. Additionally, 
pre-existing subjective poor sleep quality was an important 
contributor to the increase of the prevalence of AMS in the 
older, young adults.
Prevalence of AMS was higher in the present study than 
in two other similar altitude studies,7,8 but lower than in the 
studies by Ren et al14 and Murdoch.6 Differences between our 
study and others in terms of duration of hypoxic exposure, 
ascent rate, and age of subjects may account for this result. 
The prevalence of AMS in the study by Li et al8 was 40%; 
perceptibly lower than our result (54.36% in the group 
aged 20 years). The first clear difference between our 
study and that of Li et al8 is the duration of hypoxic expo-
sure, which was 24 hours in our study and 48 hours in that of 
Li et al.8 It is known that AMS is present within 6–12 hours 
after exposure to altitudes above 2,500 m, and that AMS 
Figure 3 Comparisons of heart rate (A) and arterial oxygen saturation (B) at 3,700 m.
Notes: Compared with the group aged 21–25 years: *P0.05, **P0.01. Compared with the group aged 20 years: #P0.01. Compared with the group aged 26–30 years: 
§P0.05.
Abbreviations: hr, heart rate; saO2, arterial oxygen saturation.
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Table 2 Comparison between Athens Insomnia scale score and the prevalence of insomnia
Variables Age 20 
years (n=195)
Age 21–25 
years (n=314)
Age 26–30 
years (n=238)
Age 31–35 
years (n=109)
AIss
At 500 m 2 (1–4) 2 (0–4) 2 (0–5) 3 (0–6)†
At 3,700 m 4 (2–7)¶ 4 (2–8)¶ 5 (3–9)¶†††# 7 (4–11)¶†††##*
Insomnia prevalence
At 500 m 27 (13.85%) 50 (15.92%) 49 (20.59%) 33 (30.28%)††#*
At 3,700 m 74 (37.95%)¶ 129 (41.08%)¶ 132 (55.46%)¶†††# 92 (84.40%)¶†††##**
Notes: Values are median (interquartile range) or n (%). Compared with the values obtained at 500 m: ¶P0.001. Compared with the group aged 20 years: †P0.05, 
††P0.01, †††P0.001. Compared with the group aged 21–25 years: #P0.01, ##P0.001. Compared with the group aged 26–30 years: *P0.05, **P0.001.
Abbreviation: AIss, Athens Insomnia scale score.
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symptoms gradually resolve within 48 hours if 1 day of rest 
or other interventions are undertaken.4 Thus, the prevalence 
of AMS would be substantially affected by the duration of 
hypoxic exposure. In our study, the mean age in the groups 
aged 20, 21–25, 26–30, and 31–35 years was 19, 22, 27, 
and 33 years, respectively; whereas that of Li et al8 was 
18 years. Notably, with the same ascent rate and altitude, as 
well as a big sample size, there is good comparability and 
strength between our study and that of Li et al.8 In the study 
by Moraga et al7 the prevalence of AMS was 56%, which was 
a little lower than in the group aged 21–25 years (59.55%) in 
our study. The discrepancy may be partially because of the 
slower ascent rate (approximately 435 m/hour) in Moraga 
et al.7 Moreover, in other research with a large sample size, 
Murdoch6 reported an AMS prevalence of 84% at 3,860 m, 
wherein subjects flew directly to 3,740 m and slept at 3,860 
m. Age of the subjects in Murdoch’s study6 was clearly higher 
(mean age 26 versus 45 years) than in our study, which may 
at least partly explain the difference in prevalence of AMS 
between the two studies. At the same time, we also noted one 
other similar altitude and ascent rate study (Ren et al).14 With 
an average subject age of 18 years, the AMS prevalence in 
the study by Ren et al14 was 57.2%, which was higher than 
that for the group aged 20 years (54.36%) in the present 
study. The discrepancy may be mainly due to the different 
scoring system for the assessment of AMS used in our study 
and that of Ren et al.14 Through comparison of the studies by 
Li et al8 and Ren et al14 we can clearly see that the prevalence 
of AMS diagnosed by the Chinese criteria is higher than the 
Lake Louise criteria. In the present study, we found that 
higher age was a risk factor for AMS (adjusted OR 1.07, 
95% CI 1.01–1.13, P=0.03), adjusted for smoking, SaO
2
, and 
AISS. However, this is in contrast to a previous study.5 After 
careful assessment, we think the difference in ascent profile 
between our study and that of Wu et al5 may mainly account 
for the result. On the other hand, after arrival at high altitude, 
the subjects in the present study mainly rested in their rooms. 
The subjects in the study by Wu et al5 did not rest, and the 
authors thought younger people were at higher risk of AMS 
than older people because of vigorous physical activity after 
arrival at high altitude. Notably, another two recent studies15,16 
have suggested that older subjects may experience higher 
AMS prevalence upon rapid ascent to high altitudes.
A significant increase in HR was observed in the whole 
group after arrival at altitude, and, furthermore, a more marked 
increase was observed in older subjects. This is supported by 
the literature.17,18 Conversely, SaO
2
 decreased in each group, 
and a slightly larger decrease was observed in older subjects. 
At the same time, correlational analysis showed that there was 
a weak correlation between age and HR (r 0.064, P=0.048), 
as well as SaO
2
 (r -0.072, P=0.029). The lower SaO
2 
values 
may mean that the older subjects experience more severe 
hypoxia. Therefore, the HR increased more markedly in the 
older subjects in response to the more severe hypoxia.
Poor subjective sleep in the general population is very 
common in modern societies, and can be caused by diversi-
form factors (eg, aging, physical and mental illness, etc).19 
In terms of different definitions, the prevalence of insomnia 
ranges from 5% to 50%,20 and the symptoms of insomnia 
increase with age in men.21 However, whether the sleep status 
of the subjects prior to the ascent would affect the prevalence 
of AMS is unclear, and furthermore, the sleep status of the 
subjects cannot be completely presented by the Lake Louise 
diagnostic criteria for AMS. Therefore, the AIS was used in 
our study to assess the sleep status of the subjects at both 
500 m and 3,700 m. Consistent with previous studies,21–23 we 
found that AISS and prevalence of insomnia increased with 
age among young adult Chinese men at 500 m (Table 3), and 
the prevalence of insomnia was within the reported range 
(5%–50%). After high altitude exposure, the prevalence of 
insomnia markedly increased in each age group, which is 
consistent with a previous study conducted with the AIS.24 
Furthermore, increase in insomnia in the older age group was 
more marked (2.79 versus 2.74, 2.58, and 2.69 times) (Table 3). 
High altitude hypoxia is one important reason for sleep 
impairment;25,26 however, existing poor subjective sleep 
status before the rapid ascent may be another important 
contributor to the increase in insomnia in the present study. 
Moreover, the AISS was positively correlated with age and 
LLS, and was a risk factor for AMS (adjusted OR 1.39, 95% 
Table 3 Correlations of lake louise score with age, heart rate, 
arterial oxygen saturation, and Athens Insomnia scale score
LLS Age HR  
(3,700 m)
SaO2  
(3,700 m)
AISS 
(3,700 m)
ρ 0.111 0.127 -0.127 0.659
P-value 0.01 0.001 0.001 0.001
Abbreviations: AIss, Athens Insomnia scale score; hr, heart rate; lls, lake 
louise score; saO2, arterial oxygen saturation; ρ, correlation coefficient.
Table 4 Multivariate logistic regression analysis
Variables β SE Wald P-value OR (95% CI)
Age 0.070 0.032 4.709 0.05 1.07 (1.01–1.13)
AIss 0.328 0.042 59.749 0.001 1.39 (1.28–1.51)
Note: Dependent variable: acute mountain sickness.
Abbreviations: AISS, Athens Insomnia Scale score; CI, confidence interval; OR, 
odds ratio; se, standard error.
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CI 1.28–1.51, P0.001). In combination, our data showed 
that poor subjective sleep quality was one important reason 
why the older, young adult Chinese men were at high risk 
of AMS upon rapid ascent to high altitude.
In the present study, we also observed that smoking and 
high SaO
2
 were significant protective factors against AMS 
by univariate analysis; however, the significance disappeared 
when adjusted for other significant predictors in the multi-
variate analysis. These results may reveal that there remain 
correlations between AMS and smoking status and SaO
2
; 
however, further work is needed to explore whether smoking 
status and SaO
2
 level are sensitive predictors for AMS.
The strengths of the present study are the large sample 
sizes, the identical ascent profile, and controlled physical 
activity. However, the present study has some limitations. 
First, the participants were all male, which could probably 
introduce a sex bias. Second, no participants were older than 
35 years, which, therefore, makes it hard to extend our results 
to other age groups. Therefore, further research involving 
females and older subjects should be conducted to confirm 
these findings.
Conclusion
The present study suggests that ‘older’ age is an independent 
risk factor for AMS upon acute exposure to high altitude 
among young adult Chinese men, and sustained poor subjec-
tive sleep prior to ascent may be an important contributor to 
an increased prevalence of AMS in the older subjects. With 
the development of transportation in our modern society, 
it is realistic to expect that more and more people could 
rapidly ascend to high altitudes. A better understanding of 
the relationship between age and AMS could lead to highly 
effective prevention of AMS. Thus, the present study may 
have implications for the prevention of AMS among older 
populations upon rapid ascent to high altitudes. Further 
research involving females and subjects older than 36 years 
should be conducted to confirm the present results.
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